[go: up one dir, main page]

Winer et al., 2002 - Google Patents

Primary Sjögren's syndrome and deficiency of ICA69

Winer et al., 2002

Document ID
2154167537849058101
Author
Winer S
Astsaturov I
Cheung R
Tsui H
Song A
Gaedigk R
Winer D
Sampson A
McKerlie C
Bookman A
Dosch H
Publication year
Publication venue
The Lancet

External Links

Snippet

Background Sjögren's syndrome is a common (about 1% of the population) autoimmune disease of salivary and lacrimal glands. Its cause and pathogenesis are poorly understood, and treatments are mostly for symptoms of the disease. ICA69 is a self-antigen expressed in …
Continue reading at www.thelancet.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Winer et al. Primary Sjögren's syndrome and deficiency of ICA69
Zhang et al. Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis
Bonito et al. Medullary thymic epithelial cell depletion leads to autoimmune hepatitis
Weetman et al. Autoimmune thyroid disease: further developments in our understanding
Lopez et al. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features
Akirav et al. The role of AIRE in human autoimmune disease
Hansen et al. New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers
Adzemovic et al. Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats
Zhou et al. Regulatory T cells but not T helper 17 cells are modulated in an animal model of Graves’ hyperthyroidism
Hünemörder et al. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis
Van Blokland et al. Two different types of sialoadenitis in the NOD-and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
Peferoen et al. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice
Vosters et al. Interleukin‐12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome
Zheng et al. Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats
Wang et al. CD8+ regulatory T cells induced by T cell vaccination protect against autoimmune nephritis
Harrison Risk assessment, prediction and prevention of type 1 diabetes
Schulten et al. Allergen and epitope targets of mouse-specific T cell responses in allergy and asthma
Kovacevic et al. Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice
Malkiel et al. Autoimmune myocarditis does not require B cells for antigen presentation
Boldison et al. A novel pathogenic RBP‐3 peptide reveals epitope spreading in persistent experimental autoimmune uveoretinitis
Kurien et al. Immunization with 60 kD Ro peptide produces different stages of preclinical autoimmunity in a Sjögren's syndrome model among multiple strains of inbred mice
Fan et al. Compromised central tolerance of ICA69 induces multiple organ autoimmunity
McGrath-Morrow et al. IL-12 overexpression in mice as a model for Sjogren lung disease
Takacs et al. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread
Delaleu et al. Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437–460